Join us to meet Seegnal CEO Eyal Shneid
and hear about the latest developments
and the pre-IPO investment opportunity
Seegnal
A groundbreaking SaaS company that has developed software enabling physicians to recommend personalized medication for patients, is in the final stages before its anticipated IPO on the Canadian stock exchange
This is your opportunity to invest in an investment that may yield returns in the short term alongside the major “Mical” group
On Wednesday, June 21 at 8:00 PM, we will meet for a special webinar to hear about the new developments and the opportunity to invest before the major breakthrough!
(Limited seats available)
Register for the webinar
One in four people will suffer severe side effects (including death) in their lifetime due to incorrect medications
Each year in the United States, $40 billion is spent treating problems caused by administering incorrect medications to patients
The phenomenon of administering incorrect medications is currently considered the fourth leading cause of death worldwide!
The company has developed a decision support system that helps physicians and pharmacists provide personalized medication treatment to patients (including pharmacogenetics), alerts about medications that contradict other medications or the patient’s medical data, and even recommends alternative medication treatment, thereby significantly reducing and even preventing the phenomenon
Seegnal’s system is operational and already in use by thousands of physicians, scanning over one million medications per day
Seegnal is experiencing business momentum worldwide – this is your opportunity to participate in its success
» In Israel, the system is already being implemented in the systems of Maccabi, Leumit health funds, and Rambam Medical Center.
» Following a successful pilot in Abu Dhabi, the system has been implemented in the first hospital, and negotiations are currently underway regarding the remaining 24 hospitals in the network.
» Seegnal’s system is generating significant enthusiasm in North America as well, and the company has signed partnership and distribution agreements with international companies in the medical information sector.
» After years of research in leading American hospitals and institutions, Seegnal is in the midst of penetrating the American market.
Do not miss this opportunity, register for the webinar now!